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Abstract
There are many transcriptional regulators found in pathogenic Staphylococcus
aureus. Many of these regulators are essential for the organism’s ability to switch from
commensal form to the virulent pathogenic form. One of these main regulators is CodY.
This regulator has been shown to be responsive to nutrient availability during phases of
growth. Additionally, we have recently found that MsaB, the only protein coding ORF of
the msaABCR operon, is a putative co-regulator of capsule along with CodY. To explore
these regulator interactions, we produced mutations of codY and msaABCR individually
and a double mutation of msaABCR/ codY. We have observed that both MsaB and CodY
bind to the cap promoter region in very close proximity. CodY binds to this region in
early phases of growth in response to nutrients as a repressor of cap transcription and
MsaB binds to this region in the later phase of growth as an activator of cap transcription.
Using a chemically defined medium (CDM), we have shown that the msaABCR operon
and ultimately MsaB is also likely involved in sensing nutrient availability. In this study,
we show that the transcriptional regulator, MsaB, interacts with another known DNA
binding transcriptional regulator, CodY, in S. aureus. These interactions are important in
the regulation of sensing environmental nutrients and regulating capsule production in S.
aureus.
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Chapter I: Introduction
The purpose of this study is to gain more insight on the transcriptional regulation
of capsule production in Staphylococcus aureus. Because of the increasing inefficacy of
current microbial treatments, there has been a shift in the field of microbiology to
examine molecular pathways involved in the expression of virulence factors employed by
the pathogen during a successful infection. This information will lead to the development
of more specific treatments that silence expression pathways that make the pathogen
more virulent. Gyan Sahukhal and Mohamed Elasri (2014) identified a four-gene operon,
msaABCR, in S. aureus. The study also specifically defined MsaB, the only protein
produced by the operon, as a regulator of virulence in S. aureus. Another protein, CodY,
has been identified as a direct link between virulence and nutrient availability in the
different phases of growth (Pohl, et. al 2009). We further examined the role of MsaB and
CodY proteins in the regulation and production of capsule in S. aureus and studied the
different nutrient conditions surrounding the expression of capsule.
Justification
Since the recent discovery of the protein, MsaB, as a regulator, there has been
limited published research on the specific actions of MsaB during the expression of
capsule. This study is unique because it looks closely at the interaction of CodY and
MsaB at the capsule promoter region in S. aureus. Research in the field has identified that
nutrients influence the production of capsule in S. aureus, but there has not been any
direct mechanism of this nutrient dependent regulation identified. We gain more insight
on the regulation and expression of capsule in S. aureus in this study.
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Methods
To examine the regulatory relationship between MsaB and CodY, singleCodY,
single mutations of codY and msaABCR as well as a double codY/ msaABCR mutant were
analyzed to see how the mutations effected capsule expression compared to the wild type
strain. E. coli was used as an expression system to express and purify MsaB protein as
was done in previous work (Batte, et. al., 2016). This protein was used to perform
binding assays and investigate what nutrient conditions hinder or promote capsule
production.
The Chromatin Immunoprecipitation assay was used to determine if and in what
phase of growth CodY and MsaB bind to the capsule promoter region. ChIP analysis
involves using an antibody produced specific to the desired protein to bind to the proteinantigen complex formed in a crosslinked treated total cell lysate (Das et. al, 2004). We
harvested cells during the different phases of growth and grown under different
conditions to discover when MsaB and CodY are bound to the capsule promoter region.
Outcomes
We hypothesize that both MsaB and CodY bind to the cap promoter region in
very close proximity in different phases of growth. We hope to determine if CodY binds
to this region in early phases of growth as a repressor of cap transcription and if MsaB
binds to this region in the later phase of growth as an activator of cap transcription.
Other groups have shown that CodY responds directly to nutrient availability (Pohl et al,
2009). Using chemically defined medium or CDM also determined that MsaB is
involved in sensing nutrients in the cell.
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As growth continues, and the bacteria start to use up the nutrients in the media,
CodY loses its affinity to bind the capsule promoter region and then MsaB binds to
promote the capsule expression. In the nutrient depleted condition, MsaB binds to the cap
promoter region in earlier phases of growth. By observing the activity of the capsule
promoter region in the codY mutant and msaABCR mutant more information was
uncovered on the other pathways the organism employs to produce capsule and persist in
its’ environment.
Significance
Methicillin resistant S. aureus is a priority for disease control due to infections
being able to quickly escalate to a medical emergency. The rising ineffectiveness of
current antibiotics creates a crisis in medicine as microbial mutation and contact
continues to increase. As a result, there is a growing section of research focused on the
study of the genetic pathways that make S. aureus more virulent. This study looks at how
the cell’s environment plays a role in the regulation of transcriptional factors. This
regulation then affects the translation of virulent factors. Capsule is the specific virulence
factor looked at in this study. The capsule enables the cell to resist phagocytosis by
immune cells (Voyich et. al, 2005). Encapsulated organisms are found in asymptomatic
colonization, abscesses and septicemia, which can lead to complex and life threatening
infections. Outlining the transcriptional factors involved in the genetic pathway of
capsule production in S. aureus will lead to the development of a new generation of
antimicrobials. These antimicrobials could be developed to directly target certain
virulence factors including capsule and lead to hindering the cell’s ability to establish
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infection. The less virulent cell would be more susceptible to antibiotics and the host’s
immune cells, which could produce better patient outcomes.
Chapter II: Literature Review
Staphylococcus aureus is one of the major causes of fatal nosocomial infection in
hospitals. One of the reasons why this bacterium is so successful at infecting even the
healthiest of individuals is because it contains a vast collection of virulence factors
(Cassedevall and Pirfoski, 2001). These virulence factors include phenotypic
characteristics, such as a polysaccharide capsule, and the bacteria’s ability to resist
antibiotic treatment. The Centers for Disease Control and Prevention reported the first
case of vancomycin resistant Staphylococcus aureus in 2002 (Goldrick, 2002). This was
alarming because vancomycin is used to treat methicillin resistant S. aureus strains as a
drug of last resort or (DoLR). The increase in the rate of bacterial success in infection and
colonization of the host creates a crisis in healthcare that calls for a more effective
treatment and understanding of the transcriptional pathways that lead the production of
the virulence factors that S. aureus employs during the infection. Not all colonization of
S. aureus is harmful to the host. In fact, a large percentage of the population is colonized
by S. aureus and experience no symptoms (Graham et al, 2006). S. aureus colonization
becomes infectious when the organism switches from commensal to virulent form. An
understanding of the environmental conditions and genetic pathways that cause this
bacterium to switch from benign to virulent could be used to develop new types of
therapies that target these specific pathways and therefore reduce the success of the
pathogen.
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Genetic Regulation of Virulence in S. aureus
The accessory gene regulator, agr, and the staphylococcal accessory gene
regulator, sar, are two important global regulatory pathways for the expression of
virulence in S. aureus (Dunman, 2001). Agr is responsible for quorum sensing of the cell
(Queck et. al, 2008). Quorum sensing involves regulating expression of certain genes in
response to cell-population densities toward the later stages of growth, such as the postexponential phase (Queck et. al, 2008). A study done by Chan and Foster (1998)
identifies the agr locus is also activated by the protein produced by the sar locus, sarA.
SarA is a regulatory DNA binding protein that can regulate virulence expression through
the agr locus by binding to the promoter regions, P1 and P2 (Dunman, 2001). SarA is
also capable of regulating virulence independent of the agr locus (Dunman, 2001). The
independent method of activating virulence involves direct interaction between SarA and
the regions of noncoding DNA that regulate the transcription of virulence factors
(Dunman, 2001). The study identifies SarA as a signal transducer that responds to oxygen
and carbon dioxide availability in the cell (Dunman, 2001). Sambanthamoory et. al
(2006) discovered a region of DNA that modifies the production and function of SarA
and named it msa, modulator of sarA. This study suggests that it is a membrane protein in
which mutation cause a decreased expression of SarA and virulence. These discoveries
lead to studies that identified and defined the regulatory mechanisms employed by msa or
(modulator of sarA). Gyan Sahukhal and Mohamed Elasri (2014) examined a msa
deletion mutant and found that the deletion had an effect of the genes just upstream of
msa. This study found that the msa was a part of a four-gene operon, msaABCR, that
regulates many of virulence factors in S. aureus. The msaABCR operon is made up of
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msaA, msaB, msaC (previously known as msa), and msaR. msaB is the only region of the
operon that codes for a 66-amino acid protein named MsaB protein. The study identified
MsaB as a regulator of several virulence factors, but does not describe how the protein
interacts with other factors or what causes the cell to employ that pathway of gene
expression. Further research is needed on the relationship between MsaB, SarA, and agr
in expression of virulence.
Capsule
The main virulence factor of my interest is the production of a capsule, an
extracellular polysaccharide covering produced by the cell. The capsule protects the cells
during harsh environments by helping it to resist desiccation and nutrient loss. Capsule
serotype 5 and 8 are predominately found in clinical environments (O’Riordian and Lee,
2004). The capsule boosts the success of S. aureus in the bloodstream by preventing
phagocytosis by leukocytes (Karakawa et. al 1998). O’Riordian and Lee (2004) further
supported this observation with the finding that the two major opsonins, complement and
antibody, were unable to bind to the encapsulated strains and therefore inhibiting
leukocytic opsonophagocytosis. Many studies have shown that capsule production is
highly sensitive to environmental signals. Herbert et. al (1997) showed that capsule
serotype 5 production is dependent of carbon dioxide availability. Lee et al (1993)
demonstrated that increased iron levels in growth conditions limited the production of
capsule serotype 8. Capsule production is maximally expressed during the post
exponential growth phase in in vitro models (Pöhlmann-Dietze, 2000). Luong et. al
(2002) showed that the agr locus plays a role in the expression of capsule by quorumsensing. Therefore, as the bacteria continue to grow in a set amount of media, the

6

increasing number of organisms start to deplete the nutrients and the density of the
bacteria increases. These factors put the bacteria under stressful conditions in which
prompt the production of virulence factors such as the capsule for protection.
The Role of codY in S. aureus
The idea of the cell sensing nutrients and then adapting its phenotype to best fit its
environment lead to studies on the gene, codY. A study done by Pohl et. al (2009)
demonstrated the sensitivity of CodY protein to nutrients and its regulation of virulence.
The study suggests that under conditions of amino acid surplus, CodY represses the
virulence genes that would help the bacteria live in limited nutrient environments. codY
null mutants and wild type strains were grown in chemically defined media (CDM)
containing all three-branched chain amino acids (BCAAs), valine, leucine, and
isoleucine. Analysis of this data showed that the codY mutants grew more slowly than
wild type in the CDM. Because codY works as a repressor of virulence, it masks many of
the virulence factors that would help the bacteria survive in low nutrient environments.
Majerczyk et al. (2010) identified that CodY was active by the presence of BCAAs. They
also found that CodY controls the expression of virulence genes through sensing nutrients
in the cells’ environment. They also noted that CodY represses some genes of the cap
locus directly and through a agr locus dependent manner. Pohl et. al (2009) found that
isoleucine specifically has a more dominant effect on CodY compared to the other
branched chain amino acids (BCAAs). This suggests that genes needed for growth are
repressed by CodY during heavy isoleucine concentrations, which indicates that
isoleucine is a major ligand regulating CodY repression of virulence. More research is
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needed on the interactions on agr, SarA, MsaB, and CodY in relation to the environment
to completely outline the transcriptional pathway of capsule production in S. aureus.
Protein Purification and Expression
Studying the interactions of CodY and MsaB require purified protein samples of
each. Bornhorst, et. al (2000) detailed an efficient way of producing a large amount of
desired protein using E. coli as an expression vector. The construction of the plasmid
involves amplifying the region of DNA that codes for the protein from the organism that
will be produced. This region is then ligated into a digested plasmid with six amino acid
histidine tags. The plasmid is then transformed into E. coli and it contains instructions in
its own genetic material on how to create the protein from the organism. Harvesting the
protein from the E. coli involves growing and lysing the cells and then separating the
protein from the cell debris by centrifuging the sample. Centrifuging the lysed cells
leaves the protein suspended in the media and the large cell fragments spun towards the
bottom of the container. Next the lysate is run through a nickel resin column. Histidine
binds to the nickel inside the column as the lysate passes through the resin. In this study,
buffer containing 10 mM imidazole was used to wash out any undesired proteins that
may have bound to the nickel column because they contained one or two histidine tags.
After washing multiple times with the low amount of imidazole, eluting the rest of the
desired six histidine tagged protein was accomplished by increasing the amount
imidazole concentration to 250 mM. This model of protein purification can be used in
many different organismal models. Once the protein is purified, it can be used in different
binding assays to detect the region of DNA in which the protein associates.
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Protein DNA Interaction Studies
Das et. al (2004) described an assay that observes protein and DNA interactions
called chromatin immunoprecipitation, (ChIP). ChIP involves extracting the protein and
DNA complexes from whole cell fragments using an antibody generated from the protein
of interest. ChIP is a useful method for the study due to it allows to test what phase of
growth the protein associates or disassociates with the DNA region. This is especially
important because the expression of many virulence factors such as capsule have been
shown to be growth-phase dependent (Dunman, et.al, 2001).
Chapter III: Methodology
This study uncovers more information about the transcriptional mechanism S.
aureus utilizes during the different environmental conditions that it encounters,
specifically focusing on the genetic pathways involving the MsaB and CodY proteins.
CodY has been shown to be a major repressor of virulence factors in response to nutrient
availability in the different phases of growth (Pohl et. al, 2009). The protein MsaB has
been previously identified as a regulator of virulence factors but little is known about this
expression pathway (Batte, et. al, 2016). To assess the relationship between MsaB and
CodY in capsule production, we analyzed the capsule expression of a codY mutant,
msaABCR mutant, and a double msaABCR/codY mutant compared to wild type to test the
effects these mutants made on growth and regulation of capsule production. Large
amounts of CodY and MsaB protein were expressed using E. coli as an expression vector.
The purified protein can then be used to perform binding assay to the capsule promoter
region and protein interaction studies.
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Growth Curves in Chemically Defined Medium
The mutants were grown with optical density (OD) measured hourly in an
extended growth curve for at least 12 hours using chemically define media (CDM).
Similar to the study done by Pohl et.al (2009), the bacteria were grown in plain CDM and
CDM without branched chain amino acids (BCAAs) valine, isoleucine, leucine. The
strains, msaABCR mutant, msaABCR complement, and wild type were normalized to an
OD of 0.05, in CDM and incubated while shaking at 37° Celsius. The OD was measured
hourly to observe the growth rate of the msaABCR mutant and complement compared to
wild type.
Protein Expression and Purification
Purified samples of CodY and MsaB protein are needed to study the interactions
and binding sites of each. E. coli is an organism commonly used as a protein expression
vector because it is highly efficient and cost effective (Hannig, 1998). We created a
plasmid constructs with an antibiotic marker that contains the codY or msaB protein
coding region with a six-histidine tag and transform the plasmid into E. coli (Charpentier
et. al, 2004). The cells were grown in one liter of Luria-Bertani broth (LB) at 37° Celsius
for 5 hours. The cell lysate was created by using a sonicator with amplitude of 30% for
20 seconds on and 1 minute off repeated seven times. The lysate was centrifuged at
10,000 G for 20 minutes to remove cell debris. Following the Bornhorst and Falke (2000)
detailed protocol of purifying the six-histidine tag codY protein using a nickel resin
column. The lysate was run through a charged nickel resin column twice. The column
was washed with at least 40 ml of wash buffer containing 10 mM imidazole, verifying
with a negative Bradford reagent reading of the lysate that all nonspecific proteins were
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eluted through. Our protein was eluted with the elution buffer that contains 250 mM
imidazole.
Chromatin Immunoprecipitation Assay
Sengupta et. al (2004) detailed the chromatin immunoprecipitation, ChIP, assay is
used to determine if and in what phase of growth does MsaB and CodY associate with the
cap promoter region using a whole cell lysate. The codY mutant, msaABCR mutant, and
wild type were liquid cultured under two conditions (CDM and CDM with no BCAAs)
and incubating at 37° Celsius. Cells were then collected during the early-, mid-, late-, and
post-exponential phases of growth. The crosslinking reaction was initiated by treating the
cells with 1% formaldehyde and 10 nM sodium phosphate. The crosslinking reaction was
stopped when 3 M glycine was added to the solution. Spinning and washing the cultures
with an equal volume on 0.1 M phosphate buffer removed excess formaldehyde. The
cells were pelleted to remove the phosphate buffer and then resuspended in 200 uL of
immunoprecipitation (IP) buffer. After the cells were bead beaten the cells were spun to
remove cell debris. The lysate was diluted with 1 ml of IP buffer. The diluted antibody
was added to 200 uL of clear lysate and incubated at room temperature for 2 hours. The
mixture was added to Protein-G-coupled magnetic beads and incubated for one hour. A
magnetic tube holder was used to collect the antigen-antibody-bead complex washed with
tris buffer saline and ultrapure water. To reverse crosslinks, the beads were resuspended
in elution buffer an incubated 65 C overnight. Phenol-chloroform extraction method was
used to extract the DNA. Polymerase chain reaction was then used to amplify the DNA
with site specific primers.
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Chapter IV: Results
Restricted Nutrient Growth Curves
The results of the growth curve in CDM and CDM without BCAAs media are
presented in Figure 1 and Figure 2 respectively. All bacteria strains experienced an
extended lag phage in both CDM and CDM without BCAAs. There was also a slower
growth of all strains of the bacteria in either of the CDM medium compared to a rich
medium, tryptic soy broth (TSB). Additionally, all the strains had an extended lag phase
initially. However, msaABCR operon mutant showed slightly decreased growth rates and
patterns as well as a more pronounced extended lag phase compared to wild type and
complement in whole CDM media. Interestingly, in the CDM without BCAAs the wild
type and complement has a very long lag phase and seem to grow very slowly. However,
the msaABCR mutant growth is very similar, in a putative “uncontrolled” manner, in
CDM without BCAAs compared to whole CDM medium. Taken together, these results
suggest that in an unidentified mechanism the msaB and ultimately the msaABCR operon
are sensing and/or responding to changes in nutrients.
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Figure 1 Growth curve in CDM with S. aureus strains of wildtype, msaABCR
mutant, and msaABCR compliment for nine hours

Figure 2 Growth curve in CDM with no BCAAs with S. aureus strains of wildtype,
msaABCR mutant, and msaABCR compliment for nine hours
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Chromatin Immunoprecipitation Assays
Figure 3 shows results of ChIP analysis of wild type, msaABCR operon mutant,
and the codY mutant. The codY mutant had visible bands in all phases of growth. This
means that there is binding of MsaB protein to the capsule promoter region in all phases
of growth. This differs from wild type in that MsaB only binds to the cap promoter
region in late- and post-exponential phase of growth. Importantly, these results suggest
that in an undetermined mechanism that CodY, when present in wild type, is inhibiting
MsaB binding in early phases of growth. The ChIP analysis in CDM media and CDM
without BCAAs (nutrient limited conditions) revealed that MsaB binds to the cap
promoter region in the mid-exponential phases of growth in wild type, independent of
CodY presence. Interestingly, in limited nutrient conditions even in conditions when
CodY is supposed to be bound (whole CDM) MsaB binds independently of CodY shown
in Figure 4. This data suggest that MsaB may be sensing nutrient availability itself
altering its binding ability to its target. However, more work needs to be done to establish
this putative nutrient sensing mechanism of MsaB.

Figure 3 ChIP analysis in TSB of S. aureus wildtype, msaABCR mutant, ccpE
mutant, and codY mutant in early, mid, late, post phases of growth
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Figure 4 ChIP analysis of CDM and CDM with no BCAAs of S. aureus wildtype,
msaABCR mutant, ccpE mutant, and codY mutant in mid-exponential phase of
growth
Chapter V: Discussion
The msaABCR operon plays a role in the growth and regulatory activity or
virulence genes in nutrient limited conditions. The deletion of msaABCR operon altered
growth rate compared to wild type and the msaABCR complement, but increased
regulatory activity (binding) in wild type in the CDM media suggest that certain
mechanisms that the cell normally employs to survive were limited without the genetic
information and sensing ability of the msaABCR operon. Thus, the msaABCR operon
mutant is limited in ability to adapt its phenotype to survive in the stressful environment.
The similarity of growth in CDM media and CDM media without BCAAs suggest that
the msaABCR operon mutant is unable to sense and respond to in its environment.
However, when MsaB or the msaABCR are present in the wild type the organism is able
to respond properly to changes in nutrient levels.
Justin Batte (2016) previously showed that the regulation of MsaB and capsule
production in S. aureus is linked to nutrient availability. MsaB was found to bind to the
capsule promoter region only in the late phases of growth (Batte, et al, 2016). In the early
phases of growth MsaB does not bind to the capsule promoter region and there is no
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capsule production. This coincides with nutrient availability in the cell’s environment. In
the later phases of growth, there is limited nutrition. This triggers the activation (MsaB
binding) resulting in capsule production. The result of the ChIP analysis in CDM media
and CDM without BCAAs shows that MsaB is responding to nutrient availability. CDM
media is much more minimal in nutrients compared to TSB. The limited environment
places enough stress on the cell to produce activation of capsule production, as evidenced
by MsaB binding to the capsule promoter region in the mid-exponential phase of growth.
Additionally, in rich nutrient conditions in the codY mutant, MsaB bound in all phases of
growth. Without this global regulator (repressor), the cell does not respond to the
nutrients in its environment. This suggests that MsaB binds to its target site when the
known repressor of capsule, CodY, loses its affinity to the site and detaches. This
detachment of CodY to its region makes the MsaB binding site accessible for binding.
More research is needed to identify other transcriptional factors or nutrient stimuli
involved in the translation of capsule production in S. aureus. In the future, it is important
to uncover more information about specific nutrients and other signals that stimulate this
process. We hope to gain more knowledge on how significant the msaABCR operon and
codY is in sensing nutrients as well as what specific nutrients have a dominant effect on
the regulation of different virulent factors.
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